Aggressive breast cancer in western Kenya has early onset, high proliferation, and immune cell infiltration
Rispah T. Sawe(Maseno University), Laurie E. Littlepage(University of Notre Dame), David Chumba(Moi University), Kirtika Patel(Moi University), Simeon Mining(Moi University), Zonggao Shi(University of Notre Dame), M. Sharon Stack(University of Notre Dame), Jingmeng Xie(University of Notre Dame), Jenifer R. Prosperi(Mike and Josie Harper Cancer Research Institute), Maggie Kerper(University of Notre Dame), Jun Li(Sun Yat-sen University), Mayra J. Sandoval-Cooper(University of Notre Dame), Kathy Taylor(Johannes Gutenberg University Mainz), Ayub Ofulla(Maseno University), Sunil Badve(Emory University)
Cited by 46
Related Papers
Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
|Journal of Clinical Oncology|2014|1.3k
Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells
|Oncogene|2005|305
Wnt5a Signaling in Cancer
|Cancers|2016|252